Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak
- PMID: 38440985
- PMCID: PMC10964401
- DOI: 10.1128/msphere.00729-23
Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak
Abstract
In December 2022, an alert was published in the UK and other European countries reporting an unusual increase in the incidence of Streptococcus pyogenes infections. Our aim was to describe the clinical, microbiological, and molecular characteristics of group A Streptococcus invasive infections (iGAS) in children prospectively recruited in Spain (September 2022-March 2023), and compare invasive strains with strains causing mild infections. One hundred thirty isolates of S. pyogenes causing infection (102 iGAS and 28 mild infections) were included in the microbiological study: emm typing, antimicrobial susceptibility testing, and sequencing for core genome multilocus sequence typing (cgMLST), resistome, and virulome analysis. Clinical data were available from 93 cases and 21 controls. Pneumonia was the most frequent clinical syndrome (41/93; 44.1%), followed by deep tissue abscesses (23/93; 24.7%), and osteoarticular infections (11/93; 11.8%). Forty-six of 93 cases (49.5%) required admission to the pediatric intensive care unit. iGAS isolates mainly belonged to emm1 and emm12; emm12 predominated in 2022 but was surpassed by emm1 in 2023. Spread of M1UK sublineage (28/64 M1 isolates) was communicated for the first time in Spain, but it did not replace the still predominant sublineage M1global (36/64). Furthermore, a difference in emm types compared with the mild cases was observed with predominance of emm1, but also important representativeness of emm12 and emm89 isolates. Pneumonia, the most frequent and severe iGAS diagnosed, was associated with the speA gene, while the ssa superantigen was associated with milder cases. iGAS isolates were mainly susceptible to antimicrobials. cgMLST showed five major clusters: ST28-ST1357/emm1, ST36-ST425/emm12, ST242/emm12.37, ST39/emm4, and ST101-ST1295/emm89 isolates.
Importance: Group A Streptococcus (GAS) is a common bacterial pathogen in the pediatric population. In the last months of 2022, an unusual increase in GAS infections was detected in various countries. Certain strains were overrepresented, although the cause of this raise is not clear. In Spain, a significant increase in mild and severe cases was also observed; this study evaluates the clinical characteristics and the strains involved in both scenarios. Our study showed that the increase in incidence did not correlate with an increase in resistance or with an emm types shift. However, there seemed to be a rise in severity, partly related to a greater rate of pneumonia cases. These findings suggest a general increase in iGAS that highlights the need for surveillance. The introduction of whole genome sequencing in the diagnosis and surveillance of iGAS may improve the understanding of antibiotic resistance, virulence, and clones, facilitating its control and personalized treatment.
Keywords: GAS; M1UK; Streptococcus pyogenes; children; invasive disease; outbreak.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.J Clin Microbiol. 2024 Oct 16;62(10):e0076624. doi: 10.1128/jcm.00766-24. Epub 2024 Aug 28. J Clin Microbiol. 2024. PMID: 39194268 Free PMC article.
-
[Prevalence of the M1UK sublineage among emm1 Streptococcus pyogenes invasive strains isolated in the Czech Republic from December 2022 to May 2023].Epidemiol Mikrobiol Imunol. 2024;73(2):76-83. doi: 10.61568/emi/11-6306/20240424/137080. Epidemiol Mikrobiol Imunol. 2024. PMID: 39060098 Czech.
-
Characteristics of Streptococcus pyogenes causing invasive infections among adults in Portugal, 2016-2019: Pre-COVID-19 expansion of the M1UK sublineage.J Microbiol Immunol Infect. 2025 Jun;58(3):333-339. doi: 10.1016/j.jmii.2025.01.009. Epub 2025 Feb 20. J Microbiol Immunol Infect. 2025. PMID: 40021403
-
Mediastinitis secondary to invasive infection by group A Streptococcus in Spain.Eur J Pediatr. 2024 Jan;183(1):503-507. doi: 10.1007/s00431-023-05288-3. Epub 2023 Oct 27. Eur J Pediatr. 2024. PMID: 37889290 Review.
-
Invasive Group A Streptococcal Infections in Europe After the COVID-19 Pandemic.Dtsch Arztebl Int. 2024 Oct 4;121(20):673-680. doi: 10.3238/arztebl.m2024.0127. Dtsch Arztebl Int. 2024. PMID: 38961826 Free PMC article. Review.
Cited by
-
Streptococcus pyogenes in Neonates and Postpartum Women: First Report on Prevalence, Resistance, emm Typing, and Risk Factors in Khyber Pakhtunkhwa.Pol J Microbiol. 2025 Jun 18;74(2):262-274. doi: 10.33073/pjm-2025-021. eCollection 2025 Jun 1. Pol J Microbiol. 2025. PMID: 40544516 Free PMC article.
-
Group A Streptococcus Infections in Children: Epidemiological Insights Before and After the COVID-19 Pandemic.Pathogens. 2024 Nov 15;13(11):1007. doi: 10.3390/pathogens13111007. Pathogens. 2024. PMID: 39599560 Free PMC article. Review.
-
Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps.Pharmacol Res. 2024 Jun;204:107188. doi: 10.1016/j.phrs.2024.107188. Epub 2024 May 3. Pharmacol Res. 2024. PMID: 38705262 Free PMC article. Review.
-
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain.Rev Esp Quimioter. 2024 Dec;37(6):454-471. doi: 10.37201/req/067.2024. Epub 2024 Jul 30. Rev Esp Quimioter. 2024. PMID: 39076142 Free PMC article.
-
Characterization of Streptococcus pyogenes Strains from Tonsillopharyngitis and Scarlet Fever Resurgence, 2023-FIRST Detection of M1UK in Bulgaria.Microorganisms. 2025 Jan 16;13(1):179. doi: 10.3390/microorganisms13010179. Microorganisms. 2025. PMID: 39858946 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) . 2022. Increase in invasive group A Streptococcus infections. Atlanta: CDC. Available from: https://www.cdc.gov/groupastrep/igasinfectionsinvestigation.html#:~:text...
-
- Cobo-Vázquez E, Aguilera-Alonso D, Carbayo T, Figueroa-Ospina LM, Sanz-Santaeufemia F, Baquero-Artigao F, Vázquez-Ordoñez C, Carrasco-Colom J, Blázquez-Gamero D, Jiménez-Montero B, Grasa-Lozano C, Cilleruelo MJ, Álvarez A, Comín-Cabrera C, Penin M, Cercenado E, Del Valle R, Roa MÁ, Diego I-D, Calvo C, Saavedra-Lozano J. 2023. Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain. Eur J Pediatr 182:3057–3062. doi:10.1007/s00431-023-04967-5 - DOI - PubMed
-
- Villalón P, Sáez-Nieto JA, Rubio-López V, Medina-Pascual MJ, Garrido N, Carrasco G, Pino-Rosa S, Valdezate S. 2021. Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019. Eur J Clin Microbiol Infect Dis 40:2295–2303. doi:10.1007/s10096-021-04279-2 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials